Kevin Andrew Lawson, MD
Orthopedic Surgery · Auburn
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
Offices
3 locations · Multicare Health System · 2,312 clinicians in this group
Hospitals listed: Multicare Auburn Medical Center · Multicare Covington Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Lawson’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A159063 · Cancelled
Licence status: Cancelled · since 2018 · Jefferson Medical College of Thomas Jefferson University.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Washington MD.MD.61019205Physician And Surgeon License · since 2020 · expires 2028-09-09ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Multicare Auburn Medical CenterAuburn, WAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Multicare Health System, which runs 11 hospitalsPatients rate it 2 of 5 · 54% would definitely recommend itOverall rating: 2 of 5 starsNo measure marked better or worse than the national rate
- Multicare Covington Medical CenterCovington, WAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Multicare Health System, which runs 11 hospitalsPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Multicare Auburn Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 0 better, 7 the same, 1 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.26 (0.21 to 2.32) · 366 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.61 to 1.44) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 10.8 · 46 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.2 · 179 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 20.4 · 208 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 154 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 1,434 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 2,428 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.33 (0.12 to 0.54) · 2,460 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.94 (0.52 to 5.36) · 374 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.37) · 85 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.19 (0.51 to 3.88) · 356 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.57 (1.15 to 20) · 86 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.66 (1.57 to 9.75) · 76 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 76 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.62 (0 to 1.52) · 1,992 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 38 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.303 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.433 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.695 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.492 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 135 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.8 · 365 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -0.6 · 58 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.6 · 190 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 15.5 · 176 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.6 · 353 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 112 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.9 (10.8 to 20) · 149 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.7) · 174 cases | No different | Jan 2024 – Dec 2024 |
What patients said (737 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 60% |
| Nurses "always" communicated well | 70% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 52% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 53% |
| Staff "always" explained new medications | 64% |
| Nurses "always" explained things so they could understand | 65% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 39% |
| "YES", patients would definitely recommend the hospital | 54% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Multicare Covington Medical Center
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 4 the same, 2 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.05 (0 to 2.15) · 32 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.47 to 1.44) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9 · 33 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.9 · 75 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.7 · 147 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.2 · 61 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 824 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.44) · 1,075 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 1,054 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.49 (0.85 to 6.14) · 32 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.32 (0.59 to 4.05) · 29 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.5 (0 to 1.7) · 764 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.4 · 145 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.9 · 83 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 0.3 · 157 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17 · 268 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.5 · 88 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.7 to 1.5) · 83 cases | No different | Jan 2024 – Dec 2024 |
What patients said (447 patients answered, 18% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 64% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 67% |
| Nurses "always" treated them with courtesy and respect | 79% |
| "Always" quiet at night | 65% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$132,711
Medicare paid this office $132,711 for 238 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Replacement of knee joint, both sides of knee | 29 | $31,832 | $1,027 |
| Replacement of thigh bone and hip joint with prosthesis | 27 | $29,485 | $1,053 |
| Aspiration and/or injection of fluid from large joint | 89 | $9,751 | $65 |
| Short return visit (20+ min) | 97 | $9,139 | $70 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 19 | $9,070 | None |
See all 13 services
| Replacement of knee joint, both sides of knee | 29 | $31,832 | $1,027 |
| Replacement of thigh bone and hip joint with prosthesis | 27 | $29,485 | $1,053 |
| Aspiration and/or injection of fluid from large joint | 89 | $9,751 | $65 |
| Short return visit (20+ min) | 97 | $9,139 | $70 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 19 | $9,070 | None |
| New patient visit (45+ min) | 61 | $7,536 | $124 |
| Return visit (30+ min) | 57 | $6,087 | $95 |
| Long return visit (40+ min) | 38 | $5,346 | $141 |
| Computer-assisted surgery for muscle and bone procedure | 29 | $3,594 | $116 |
| X-ray of hip, 2-3 views | 22 | $653 | $28 |
| Short return visit | 12 | $468 | $39 |
| Injection, methylprednisolone acetate, 1 mg | 58 | $342 | None |
| Injection, methylprednisolone acetate, 40 mg | 12 | $52 | None |
Procedures Medicare counted
| Hip replacement | 31 | More than 77% of doctors who do this |
| Knee replacement | 32 | More than 66% of doctors who do this |
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 1-10 | None |
Who their Medicare patients are
238 Original Medicare patients in 2024. Average age 74 · Women 65% · Also on Medicaid 13% · Health risk score 0.96. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 31% · Depression 28% · Chronic kidney disease 22% · Coronary heart disease 20% · COPD 14% · Atrial fibrillation 14% · Cancer 13% · Heart failure 12% · Stroke 5%.
The office billed $510,554, Medicare allowed $172,921 and paid $132,711; for 5,040 services of 40 kinds; $14,863 of it was for drugs given in the office and $117,848 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 238 | 5,040 | 74 | 0.96 | $510,554 | $132,711 |
| 2023 | 256 | 1,939 | 74 | 0.90 | $442,196 | $138,232 |
| 2022 | 191 | 1,350 | 73 | 1.02 | $269,471 | $96,748 |
| 2021 | 190 | 998 | 74 | 1.16 | $233,209 | $81,499 |
| 2020 | 83 | 716 | 74 | 1.21 | $94,646 | $30,054 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Replacement of knee joint, both sides of knee | 22 | $25,304 | $1,100 |
| Replacement of thigh bone and hip joint with prosthesis | 18 | $19,779 | $1,099 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 28 | $14,515 | None |
| Short return visit (20+ min) | 120 | $12,794 | $70 |
| Aspiration and/or injection of fluid from large joint | 103 | $12,783 | $65 |
| New patient visit (45+ min) | 64 | $8,493 | $133 |
| Long return visit (40+ min) | 54 | $8,017 | $143 |
| Return visit (30+ min) | 41 | $4,450 | $99 |
| Short return visit | 35 | $4,382 | $49 |
| Computer-assisted surgery for muscle and bone procedure | 22 | $2,793 | $121 |
| New patient visit (30+ min) | 15 | $1,118 | $75 |
| X-ray of knee, 3 views | 17 | $734 | $23 |
| Injection, methylprednisolone acetate, 40 mg | 70 | $636 | None |
| X-ray of hip, 2-3 views | 16 | $503 | $31 |
2022: 10 services
| Replacement of thigh bone and hip joint with prosthesis | 13 | $15,670 | $1,119 |
| Replacement of knee joint, both sides of knee | 11 | $14,547 | $1,119 |
| New patient visit (45+ min) | 87 | $11,227 | $129 |
| Short return visit (20+ min) | 92 | $10,512 | $77 |
| Aspiration and/or injection of fluid from large joint | 88 | $10,043 | $65 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 24 | $9,418 | None |
| Long return visit (40+ min) | 36 | $5,506 | $153 |
| Return visit (30+ min) | 28 | $3,391 | $113 |
| Short return visit | 18 | $1,627 | $51 |
| Injection, methylprednisolone acetate, 40 mg | 62 | $476 | None |
2021: 7 services
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 30 | $12,697 | None |
| New patient visit (45+ min) | 90 | $11,277 | $125 |
| Short return visit (20+ min) | 83 | $10,170 | $79 |
| Aspiration and/or injection of fluid from large joint | 80 | $9,957 | $66 |
| Long return visit (40+ min) | 30 | $4,285 | $138 |
| Return visit (30+ min) | 20 | $1,701 | $85 |
| Injection, methylprednisolone acetate, 40 mg | 49 | $262 | None |
2020: 4 services
| Aspiration and/or injection of fluid from large joint | 37 | $3,651 | $60 |
| Return visit (30+ min) | 31 | $3,565 | $96 |
| New patient visit (30+ min) | 28 | $2,598 | $93 |
| Injection, methylprednisolone acetate, 40 mg | 22 | $131 | None |
Medicaid work
$10,653 in 2024
Medicaid paid $10,653 for 385 billed services this clinician did in 2024, up to 21 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 140 | $5,090 |
| Arthrocentesis and injection of knee joint | 116 | $3,559 |
| New patient visit (45+ min) | 15 | $1,308 |
| Return visit (30+ min) | 12 | $420 |
| Injection, methylprednisolone acetate, 1 mg | 45 | $277 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 14 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 43 | $0 |
| 2024 | 385 | 7 | 21 | $10,653 |
| 2023 | 425 | 5 | 26 | $12,363 |
| 2022 | 277 | 4 | 22 | $9,004 |
| 2021 | 483 | 5 | 33 | $15,860 |
See the largest Medicaid services in earlier years
2023
| Arthrocentesis and injection of knee joint | 197 | $5,901 |
| Short return visit (20+ min) | 151 | $4,603 |
| Long return visit (40+ min) | 16 | $945 |
| New patient visit (45+ min) | 12 | $623 |
| Injection, methylprednisolone acetate, 40 mg | 49 | $290 |
2022
| Short return visit (20+ min) | 123 | $3,892 |
| Arthrocentesis and injection of knee joint | 100 | $2,923 |
| New patient visit (45+ min) | 26 | $2,053 |
| Injection, methylprednisolone acetate, 40 mg | 28 | $136 |
2021
| New patient visit (45+ min) | 115 | $7,390 |
| Short return visit (20+ min) | 168 | $5,249 |
| Arthrocentesis and injection of knee joint | 102 | $3,090 |
| Injection, methylprednisolone acetate, 40 mg | 26 | $132 |
| Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Public Health Emergency, as defined by law, due to respiratory-transmitted infectious disease | 72 | $0 |
Drugs they prescribed that Part D paid
$2,325
Pharmacies billed $2,325 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
206 generic and fewer than 11 brand-name prescriptions · $2,325 in drug cost · 18 antibiotic prescriptions to 18 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Diclofenac | 62 | $1,499 | $16 |
| Cyclobenzaprine | 32 | $291 | $7 |
| Meloxicam | 19 | $46 | $2 |
| Amoxicillin | 14 | $10 | $1 |
Year by year
| 2024 | 208 | 136 | None | None | $2,325 |
| 2023 | 239 | 145 | 9% (21) | None | $3,908 |
| 2022 | 254 | 133 | 11% (28) | 0% | $3,873 |
| 2021 | 228 | 120 | 11% (25) | None | $3,679 |
| 2020 | 93 | 61 | 17% (16) | None | $4,155 |
| 2019 | 32 | 24 | None | None | $2,264 |
| 2018 | 55 | 24 | 36% (20) | None | $887 |
| 2017 | 33 | 24 | 67% (22) | 0% | $465 |
| 2016 | 51 | 33 | 63% (32) | None | $1,210 |
| 2015 | 28 | 18 | 50% (14) | None | $545 |
| 2014 | 14 | None | None | None | $1,327 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Diclofenac | 67 | $2,289 | $34 |
| Cyclobenzaprine | 42 | $262 | $6 |
| Meloxicam | 71 | $188 | $3 |
2022: 7 drugs
| Diclofenac | 70 | $2,555 | $37 |
| Meloxicam | 81 | $328 | $4 |
| Oxycodone | 15 | $157 | $10 |
| Cyclobenzaprine | 17 | $105 | $6 |
| Cephalexin | 12 | $91 | $8 |
| Hydroxyzine Pamoate | 15 | $69 | $5 |
| Tramadol | 12 | $20 | $2 |
2021: 4 drugs
| Diclofenac | 130 | $2,857 | $22 |
| Oxycodone | 16 | $159 | $10 |
| Cyclobenzaprine | 13 | $88 | $7 |
| Meloxicam | 22 | $67 | $3 |
2020: 2 drugs
| Diclofenac | 52 | $3,021 | $58 |
| Oxycodone | 14 | $109 | $8 |
2019: 1 drug
| Diclofenac | 16 | $1,890 | $118 |
2018: 1 drug
| Gabapentin | 11 | $122 | $11 |
2017: 1 drug
| Oxycodone | 14 | $172 | $12 |
2016: 1 drug
| Oxycodone | 16 | $201 | $13 |
Money from drug and device companies
$210 in 2025
| 2025 | 4 | 4 | None | $210 |
| 2024 | 2 | 2 | None | $111 |
| 2023 | 4 | 5 | None | $333 |
| 2022 | 4 | 16 | None | $1,396 |
| 2021 | 2 | 21 | None | $719 |
| 2020 | 3 | 5 | None | $1,072 |
| 2019 | 2 | 4 | None | $349 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Zimmer Biomet Holdings | G7 | $129 | 1 payment
|
| Invictus Surgical | None | $48 | 1 payment
|
| Smith+Nephew | Legion Revision | $17 | 1 payment
|
| Merck Sharp & Dohme | Bridion | $16 | 1 payment
|
See all 4 published payments
| Merck Sharp & Dohme | Meals · 2025-06-25 | Bridion | $16 |
| Smith+Nephew | Meals · 2025-04-21 | Legion Revision | $17 |
| Zimmer Biomet Holdings | Meals · 2025-03-20 | G7 | $129 |
| Invictus Surgical | Meals · 2025-03-04 | None | $48 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $111
| Heron Therapeutics | Zynrelef | $89 | 1 payment
|
| Zimmer Biomet Holdings | Gel-One Cross-Linked Hyaluronate | $22 | 1 payment
|
2023: $333
| Zimmer Biomet Holdings | Mymobility Platform | $143 | 2 payments
|
| Becton Dickinson and | Arista Ah Flexitip | $142 | 1 payment
|
| Ethicon US | Stratafix | $25 | 1 payment
|
| Smith+Nephew | Legion Revision | $24 | 1 payment
|
2022: $1,396
| Zimmer Biomet Holdings | Arcos | $1,210 | 13 payments
|
| Smith+Nephew | Trigen Intertan | $143 | 1 payment
|
| Heron Therapeutics | Zynrelef | $30 | 1 payment
|
| Merck Sharp & Dohme | Bridion | $14 | 1 payment
|
2021: $719
| Zimmer Biomet Holdings | Persona | $706 | 20 payments
|
| Merck Sharp & Dohme | Bridion | $13 | 1 payment
|
2020: $1,072
| Summit Surgical | None | $741 | 1 payment
|
| Zimmer Biomet Holdings | Rosa-Knee | $264 | 3 payments
|
| MicroPort Orthopedics | Mpo Medial Pivot Knee | $67 | 1 payment
|
2019: $349
| Medical Device Business Services | None | $295 | 2 payments
|
| DePuy Synthes Sales | Actis | $54 | 2 payments
|
Professional record
- NPI
- 1962815886
- Licence
- AZ R74452, CA A159063, WA MD61019205California A159063: CancelledWashington MD.MD.61019205: Active
- Trained
- Jefferson Medical College of Thomas Jefferson University, 2014
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Orthopedic surgery (207X00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2014-06-09
- NPI last updated
- 2020-09-17
- NPI record certified
- 2020-09-17
This is when the NPI record was last certified, not a medical board exam.